Reduced expression of the CD44 variant exons in oral squamous cell carcinoma and its relationship to metastasis.
In the present study, we examined the expression of CD44 variant exons in human oral squamous cell carcinoma (OSCC). Of ten cell lines from OSCCs, two (KB and H357), as well as the HeLa cell line, failed to express CD44 variant exons. In surgical specimens, all normal mucosa expressed CD44v9 (both mRNA and protein). Of 40 primary OSCCs, 19 (47.5%) showed downregulation of CD44v9, which correlated with tumor cell differentiation, primary metastasis to lymph nodes and secondary metastasis to lymph nodes. The results suggest that the downregulation of CD44v9 may play a role in lymphatic metastasis of OSCC and changes in its expression may be a useful diagnostic tool to determine the metastatic potential of OSCC to lymph nodes. Moreover, three cell lines that failed to express CD44 variant exons might become a useful experimental model to study the role of variant exons in the progression of OSCC.
Department of Oral and Maxillofacial Surgery II, Hiroshima University School of Dentistry, Japan.
T
T
Ue
H
H
Yokozaki
K
K
Kagai
K
K
Higashikawa
W
W
Yasui
M
M
Sugiyama
E
E
Tahara
T
T
Ishikawa
D015153:Blotting, Western; D002294:Carcinoma, Squamous Cell / Q000235:genetics / Q000276:immunology* / Q000556:secondary; D002454:Cell Differentiation / Q000235:genetics; D018450:Disease Progression; D015536:Down-Regulation / Q000235:genetics; D004848:Epithelium / Q000276:immunology; D005091:Exons / Q000235:genetics*; D015972:Gene Expression Regulation, Neoplastic; D006367:HeLa Cells; D006801:Humans; D018960:Hyaluronan Receptors / Q000235:genetics*; D007150:Immunohistochemistry; D008207:Lymphatic Metastasis / Q000276:immunology*; D009061:Mouth Mucosa / Q000276:immunology; D009062:Mouth Neoplasms / Q000235:genetics / Q000276:immunology*; D012333:RNA, Messenger / Q000235:genetics; D014407:Tumor Cells, Cultured
D018960:Hyaluronan Receptors; D012333:RNA, Messenger